|
Q2 FY2025
As of Jun 30, 2026
|
Q1 FY2025
As of Mar 31, 2026
|
Q4 FY2024
As of Dec 31, 2025
|
Q3 FY2024
As of Sep 30, 2025
|
Q2 FY2024
As of Jun 30, 2025
|
Q1 FY2024
As of Mar 31, 2025
|
Q4 FY2023
As of Dec 31, 2024
|
Q3 FY2023
As of Sep 30, 2024
|
Q2 FY2023
As of Jun 30, 2024
|
Q1 FY2023
As of Mar 31, 2024
|
Q4 FY2022
As of Dec 31, 2023
|
Q3 FY2022
As of Sep 30, 2023
|
Q2 FY2022
As of Jun 30, 2023
|
Q1 FY2022
As of Mar 31, 2023
|
Q4 FY2021
As of Dec 31, 2022
|
Q3 FY2021
As of Sep 30, 2022
|
Q2 FY2021
As of Jun 30, 2022
|
Q1 FY2021
As of Mar 31, 2022
|
Q4 FY2020
As of Dec 31, 2021
|
Q3 FY2020
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Tax incentive and other receivables | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders' equity (deficit) | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenue, non-current | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Series C redeemable convertible preferred stock; $0.01 par value, 5,000,000 shares authorized; 12,472 and zero shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||||
| Common stock, $0.01 par value, 250,000,000 shares authorized, 15,264,812 and 9,067,774 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||||||||
| Total liabilities and stockholders' equity (deficit) |
Loading...
